JAMA Network Open· 2026Q1
Insurance Coverage and Access Requirements for Lower-Emission Inhalers in US Commercial Health Plans
- 1citations
- Q1SCImago
- 2026year
Short summary
US commercial health plans show significant variation in formulary coverage, patient cost-sharing, and prior authorization requirements for lower-emission inhalers.
AI-generated from the title and abstract; the full text is not read.
Key points
- Assessed formulary coverage for lower-emission inhalers in US commercial health plans.
- Examined patient cost-sharing and prior authorization requirements.
- Included patients with asthma or chronic obstructive pulmonary disease.
- Identified significant variation in access requirements across insurance plans.
AI-generated from the title and abstract; the full text is not read.
Abstract
This cross-sectional study assesses formulary coverage, patient cost-sharing, and prior authorization requirements for lower-emission inhalers among patients with asthma or chronic obstructive pulmonary disease across US commercial insurance plans.
The authors' abstract, as published at the source. JAMA Network Open, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Pulmonary and Respiratory Medicine
Pulmonary and Respiratory MedicineMedicine